AR134053A1 - Proceso para elaborar baloxavir marboxil - Google Patents

Proceso para elaborar baloxavir marboxil

Info

Publication number
AR134053A1
AR134053A1 ARP240102713A ARP240102713A AR134053A1 AR 134053 A1 AR134053 A1 AR 134053A1 AR P240102713 A ARP240102713 A AR P240102713A AR P240102713 A ARP240102713 A AR P240102713A AR 134053 A1 AR134053 A1 AR 134053A1
Authority
AR
Argentina
Prior art keywords
baloxavir
manufacturing
marboxyl
icm
implementation
Prior art date
Application number
ARP240102713A
Other languages
English (en)
Inventor
Keith Steven Barbato
Stephen Christopher Born
Rajshree Chakrabarty
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR134053A1 publication Critical patent/AR134053A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Animal Behavior & Ethology (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)

Abstract

La invención se refiere a un proceso novedoso para elaborar baloxavir marboxil (1) y baloxavir (1a), así como también a una implementación de elaboración continua integrada (ICM) de estos.
ARP240102713A 2023-10-05 2024-10-04 Proceso para elaborar baloxavir marboxil AR134053A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP23201730 2023-10-05

Publications (1)

Publication Number Publication Date
AR134053A1 true AR134053A1 (es) 2025-11-26

Family

ID=88291225

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP240102713A AR134053A1 (es) 2023-10-05 2024-10-04 Proceso para elaborar baloxavir marboxil

Country Status (8)

Country Link
EP (1) EP4788681A2 (es)
KR (1) KR20260085417A (es)
CN (1) CN121925422A (es)
AR (1) AR134053A1 (es)
AU (1) AU2024355785A1 (es)
IL (1) IL327495A (es)
TW (1) TW202530224A (es)
WO (1) WO2025073819A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121127476A (zh) * 2024-03-18 2025-12-12 石药集团中奇制药技术(石家庄)有限公司 多环吡啶酮衍生物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107709321A (zh) 2015-04-28 2018-02-16 盐野义制药株式会社 经取代的多环性吡啶酮衍生物及其前药
US11261198B2 (en) 2016-06-20 2022-03-01 Shionogi & Co., Ltd. Process for preparing substituted polycyclic pyridone derivative and crystal thereof

Also Published As

Publication number Publication date
WO2025073819A3 (en) 2025-05-15
CN121925422A (zh) 2026-04-24
TW202530224A (zh) 2025-08-01
IL327495A (en) 2026-05-01
WO2025073819A2 (en) 2025-04-10
EP4788681A2 (en) 2026-08-12
AU2024355785A1 (en) 2026-03-26
KR20260085417A (ko) 2026-06-09

Similar Documents

Publication Publication Date Title
CY1108917T1 (el) Ετερο υποκατεστημενοι αναστολεις διαυλου νατριου
MX2019011758A (es) Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando la misma.
MX2019011730A (es) Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando la misma.
MX2023010695A (es) Compuestos anti-virales.
MX2020012627A (es) Metodo para la produccion de compuestos monoterpenoides.
MX2023014629A (es) Nuevas formas solidas de (3r)-n-[2-ciano-4-fluoro-3-(3-metil-4-oxo -quinazolin-6-il)oxi-fenil]-3-fluoro-pirrolidin-1-sulfonamida.
MX2023002291A (es) Métodos y usos en la producción de composiciones estables que comprenden peróxidos y especies de cloro libre disponible.
MX2024009760A (es) Proceso para preparar compuestos de silicio organico.
CL2023001148A1 (es) Inductor de haploides dobles
CL2024003302A1 (es) Oligonucleótidos antisentido syf2.
AR040719A1 (es) Proceso para la produccion de una proteina heterologa
IL279168B (en) A process for the preparation of eribulin
CO2024015096A2 (es) Proceso mejorado para la fabricación de osimertinib
AR125115A1 (es) PROCEDIMIENTO PARA LA DETERMINACIÓN CUANTITATIVA DE Al₄C₃, ASÍ COMO DISPOSITIVO PARA LA REALIZACIÓN DEL PROCEDIMIENTO
CL2022001248A1 (es) Método para la producción de arn bicatenario
WO2025073819A3 (en) Process for manufacturing baloxavir marboxil
CL2024003050A1 (es) Método e intermediario para la preparación de apalutamida.
MX2022003879A (es) Proceso para elaborar acidos alcansulfonicos.
EA202192840A1 (ru) Способ получения соединений карбамоилоксиметилтриазолциклогексиловой кислоты
EP4592765A4 (en) PROCESSING CARTRIDGE
EP4140982C0 (en) PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF CARBOPROST AND CARBOPROST TROMETHAMINE, AND CARBOPROST TROMETHAMINE PREPARED THEREFROM
CR20240090A (es) Proceso para la preparación de adrenomedulina pegilada, sus intermediarios y su uso
MX2024005336A (es) Composiciones y metodos para la modulacion de inmunidad mediada por cadena beta.
JP1798243S (ja) 宝飾品
JP1798244S (ja) 宝飾品